Towards the end of the inaugural annual performance review period, the COVID-19 pandemic took hold in the UK. To learn more about participating in the study in the future, read our advert for participants (PDF) and our study participant information sheet (PDF). Recruitment for FLASH-UK is currently closed to new participants. The hand-held reader can scan through clothing and displays blood sugar level readings on the screen. The sensor is applied to the back of the upper arm with a disposable applicator. The sensor probe (0.4mm wide and 5mm in length) is inserted into the skin. Our aim is to provide sufficient evidence to enable people with diabetes to benefit from the Freestyle Libre 2 device. Without the evidence base, there is caution around providing this device to a wider group of type 1 diabetes patients. Evidence is required to guide future policy development on how the device could be used across NHS trusts. We are investigating whether the FreeStyle Libre 2 device improves blood sugar control compared to finger-prick testing in type 1 diabetics. Read more about flash glucose monitoring on the Diabetes UK website. You can find out your blood sugar levels by scanning the sensor using a separate reader.įlash monitoring is less invasive than finger prick tests and can identify trends in your sugar levels to give you more confidence in your diabetes management. It records your sugar levels continuously throughout the day and night. Giving patients an overall improved quality of life.Ī flash glucose monitor is a small sensor that you wear just under your skin.Reducing the number of hospital appointments.Patients experiencing fewer episodes of low (hypoglycaemia) and high (hyperglycaemia) blood sugar levels leading to fewer complications such as heart disease, kidney failure, and nerve damage.Good control of blood sugar is important because it is linked to: Why is good control of blood sugar levels important?
#Freestyle libre flash glucose monitoring system invasive trial
Visit Dr Sankalpa’s diabetes centre website. Dr Sankalpa Neupane – Site Principal Investigator (Norfolk & Norwich University Hospitals NHS Foundation Trust).Dr Parth Narendran – Site Principal Investigator (University Hospitals Birmingham NHS Foundation Trust.Dr Sarah Lumley – Site Principal Investigator (The Adam Practice, NHS England).Dr Naresh Kanumilli – Co-Investigator & Community Diabetes Participant Referral Champion.Dr Mark Evans – Site Principal Investigator (Cambridge University Hospitals NHS Foundation Trust).Dr Iain Cranston – Site Principal Investigator (Portsmouth Hospitals NHS Trust).
0 kommentar(er)
